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Droplet-interface-bilayer assays
in microfluidic passive networks
Ba´rbara Schlicht & Michele Zagnoni
Centre for Microsystems and Photonics, Electronic and Electrical Engineering, University of Strathclyde, Glasgow, G1 1XW, UK.
Basic biophysical studies and pharmacological processes can be investigated by mimicking the intracellular
and extracellular environments across an artificial cell membrane construct. The ability to reproduce in
vitro simplified scenarios found in live cell membranes in an automated manner has great potential for a
variety of synthetic biology and compound screening applications. Here, we present a fully integrated
microfluidic system for the production of artificial lipid bilayers based on the miniaturisation of
droplet-interface-bilayer (DIB) techniques. The platform uses a microfluidic design that enables the
controlled positioning and storage of phospholipid-stabilized water-in-oil droplets, leading successfully to
the scalable and automated formation of arrays of DIBs to mimic cell membrane processes. To ensure
robustness of operation, we have investigated how lipid concentration, immiscible phase flow velocities and
the device geometrical parameters affect the system performance. Finally, we produced proof-of-concept
data showing that diffusive transport of molecules and ions across on-chip DIBs can be studied and
quantified using fluorescence-based assays.
O
ver the past two decades, the steady development ofmicrofluidic technologies has provided sophisticated
methodologies in many areas of science, including the ability to integrate and multiplex bioassays.
The creation of biocompatible environments and the laminar flow properties of microfluidic channel
networks offer very exciting prospects for the future development of automated and high-throughput synthetic
biology-based platforms.
Of particular interest for both drug discovery and biophysical research is the ability to interrogate and
characterise the functional behaviour of membrane proteins in a reliable, scalable and miniaturised format. To
this end, either live cell systems or a simplified synthetic environment thatmimics that of a natural cell membrane
can be used. Microfluidic solutions are already commercially available (e.g. from Fluxion, Nanion Technologies,
Sophion and Ionera) that use electrophysiology techniques to measure the activity across biological membranes,
using either whole live cells1 or by inserting ion channels in artificial lipid bilayers2. The latter approach is
particularly interesting as it allows the effect of cellular parameters (e.g. membrane composition, pH and ion
channel type) to be separately investigated, this having strong implications for carrying out novel types of
experiments, for advancing biological knowledge related to membrane proteins and for facilitating the design
and testing of more effective drugs.
Microfluidic solutions have been proposed to create artificial cell membranes using immiscible fluids in silicon
and polymer substrates, where suspended lipid bilayers were formed solely by fluid phase manipulation3–7.
Alternatively, phospholipid stabilised water-in-oil (psW/O) droplets have been used to create artificial cell
membranes (known as droplet-interface-bilayers8 - DIBs). DIB formation is achieved when two psW/O droplets
come into contact and the lipid molecules at each droplet interface interact spontaneously self-assembling into a
lipid bilayer. Initially, DIB based assays have been developed by manually bringing droplets into contact but, in
recent years, more efforts have been devoted to establishing similar assays using miniaturised systems that relied
onmicromanipulators, microgeometries and dielectrophoresis9–16 or by interfacing psW/O droplets with agarose
gel layers17,18. However, these approaches present limitations due to either a lower throughput than automated
patch-clamp systems or necessitate procedures that require manual intervention. Additionally, microfluidic
systems based on arrays of individual giant-unilamellar-vesicles (GUVs) have also been reported19. Although
GUVs are a useful model for membrane morphology studies, their formation takes place outside the device and
the inner vesicle compartment cannot be easily accessed or modified.
To overcome these challenges we have developed a microfluidic solution that combines into a single device the
throughput typical of droplet microfluidic systems20 with the high degree of control over droplet positioning
obtained from bespoke microchannel networks21. The system facilitates by design the precise and automated
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fashion using fluorescence microscopy. DIBs are formed upon
contact between two psW/O microdroplets encapsulating an appro-
priate mix of proteins/compounds where one droplet mimics the
intracellular environment and the other represents the extracellular
environment. Furthermore, the implementation of fluorescence-
based assays in DIB format is directly compatible with the through-
put of droplet technologies and reduces the complexity and costs
associated with electrophysiology procedures.
In this work, a droplet-microfluidic system is presented for max-
imising the yield of formation of arrays of DIBs in a scalable format,
integrating the formation and desired positioning of psW/O drop-
lets. By encapsulating the desired cocktail of liposomes, buffers,
molecules and peptides into the psW/O droplets, a large number
of DIBs were characterized using fluorescence-based assays. Our
investigation has identified the key parameters for enabling the reli-
able formation and storage of DIB arrays, as well as the relationship
between the throughput of readout and the process dynamics
occurring across a DIB.
Methods
Materials. All chemicals were purchased from Sigma-Aldrich (UK) unless otherwise
stated. 1,2-Diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) and 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) were purchased from Avanti Polar Lipids
(Alabama, US). Fluo-8 K1 Salt was purchased from Abcam Biochemicals
(Cambridge, UK).
Device fabrication. Microfluidic devices were fabricated in polydimethylsiloxane
(PDMS) (Sylgard 184, DowCorning, US) using standard soft lithography techniques.
Silicon masters were produced using SU8 photoresist (3000 series, MicroChem, US)
on a silicon wafer following the manufacturer’s protocol. A layer of SU8 3035 was
spun to produce a final resist thickness of 50 mm. The resist was exposed through a
photomask (JD Photo-Tools, UK) to UV light and was developed in MicroPosit EC
solvent (Rohm and Haas, US). To prevent PDMS adhesion to the resulting silicon
master, the silicon surface was silanized by vapour deposition of 1H,1H,2H,2H-
perfluorooctyl-trichlorosilane for 1 hour. PDMS was then poured onto the silicon
master at a 10:1 ratio of base to curing agent, degassed in a vacuum desiccator
chamber and cured at 70uC for at least 3 hours. The PDMS devices were then peeled
from themould, cut to the desired size and holes were punched to obtain the inlet and
outlet ports. PDMS devices were then cleaned and irreversibly bonded to glass
microscope slides using oxygen plasma. Bonded devices were then flushed with
Sigmacote and air to render the channels hydrophobic.
Lipid and liposome preparation. Asolectin (a lipid mixture from soybean), DOPC
or DPhPC were used for DIB formation. An aliquot of lipids in chloroform was
evaporated under a stream of nitrogen and subsequently dried for 2 hours in a
desiccator. The lipid film was then rehydrated to the desired concentration in either
hexadecane or the desired buffer. Lipid concentrations ranging from 2 to 10 mg/mL
were tested, all of which are above the critical micelle concentration (CMC). When
dissolved in buffer, the samples were extruded 21 times through a 100 nm polycar-
bonate membrane (Avanti Polar Lipids) to produce unilamellar lipid vesicles. For
DIB leakage experiments, alternating droplets containing non-fluorescent (10 mM
HEPES, 200 mM KCl, pH 7.4 - donor droplet) or fluorescent buffers (100 mM
fluorescein or 100 mM calcein, 10 mM HEPES, 200 mM KCl, pH 7.4 - acceptor
droplet) were used. For DIB ion channel experiments, 5 mg/mL DPhPC in
hexadecane and alternating droplets containing 10 mM HEPES, 20 mM EDTA, 1 M
CaCl2, 2 mg/ml a-Haemolysin at pH 7.4 (donor droplet) and 10 mMHEPES, 333 mM
EDTA, 2 M KCl, 250 mM Fluo-8 at pH 7.4 (acceptor droplet) were used.
Coalescence experiments and fluorescence-based assays. Phospholipid stabilised
water-in-oil (psW/O) droplets were arrayed and stored within ‘‘shift-register’’
structures22 forming arrays of DIBs. The structure of a droplet shift register is
segmented in three parts: one main channel and two side gutters. The gutters and the
main channel are separated by pillars that allow the flow of the continuous phase
through, facilitating droplet arraying and trapping within the main channel
(Figure S1 in ESI).
For droplet coalescence experiments, asolectin at 5 lipid concentrations was used
22, 4, 5, 8 and 10 mg/ml. For each concentration, lipids were tested when dispersed
only in the oil phase or only in the buffer phase as liposomes or in equal concentration
in both phases. For these experiments, psW/O droplets were obtained using a device
with a single T-junction and rectangular pillars within the registers, as either droplet
alternation or long-term storage was not required. Droplet arraying and coalescence
behaviour were monitored and recorded within the registers, varying droplet
velocities in the range 10–3,000 mm/s. Any occurrence of coalescence within any
register (due to resting or moving droplets) was counted as a coalescing event.
For leakage and ion channel experiments, psW/O droplets encapsulating
fluorescent and non-fluorescent buffers were obtained using a device with a double
T-junction and a pillar structure that allowed droplets to be ‘‘locked’’ within the
register in the absence of flow to aid droplet storage over time, obtaining arrays of
droplets in ABAB configuration (Figure 1). Once all the registers were completely
filled with droplets, the fluid flow was stopped and tubing disconnected. Droplets
Figure 1 | Device geometry. (A) Schematic drawing of the microfluidic device developed. A double T-Junction was used to produce droplets
encapsulating different buffers. Images from supplementarymovies: (B) a Y-Junction enabled droplet alternation; (C) the channel structure and a by-pass
channel were designed to divert the oil phase and reduce droplet velocity after formation and before the register area; (D) a series of droplet traps (shift
registers) had an optimised pattern tomaintain droplets stored in the absence of flow. (E) Schematic drawing of a shift register that allows droplets to lock
within the pillars in the absence of oil flow for long-term droplet storage. (F) Experimental images showing the difference between droplet arrangement in
long shift registers with different shapes of pillars. The pillar structure on the left allowed droplets to remain trapped within the register when the oil flow
was stopped, while droplets on the right hand image tended to backflow or move outside the registers upon detaching the tubing at the inlets.
(G) Schematic representation of a DIB. As the tails of two lipid monolayers come into contact, a DIB is formed.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9951 | DOI: 10.1038/srep09951 2
were thenmonitored every 1–5minutes for the duration of the experiment (40min to
2 hours).
Microfluidic device operation. A commercially available pressure control system
(MFCS 4C, Fluigent) was used to independently drive the phases into the device,
applying pressure patterns typically in the range 0–150 mbar. The system allowed the
prompt generation of on-demand droplets at each T-junction by adjusting the
pressure of each phase simultaneously via computer controlled software.
An inverted microscope (Axiovert A1, Zeiss) was used for all experiments and
images acquired using either a CMOSGenie HM1024 camera (Teledyne Dalsa) via in
house written Labview software or an EMCCD LucaR camera (Andor Technologies)
via Andor Solis software. Objective lenses of 2.5x, 5x, 10x or 20x were used.
Fluorescence images were acquired using a fluorescein isothiocyanate filter (FITC)
with 200 ms exposure time. Fluorescence count from the droplets was obtained by
averaging the intensity values of a region of interest of 50350 pixels in the centre of
the droplet. ImageJ software (v1.46r) was used to analyse and process recorded
images. To test the effect of droplet coalescence at different lipid concentrations,
videos (up to 200 frames/s) were taken of the device in operation (Movies S1A-C in
ESI) with droplets travelling at different velocities (Movies S2, S3, and S4 in ESI). The
videos were subsequently examined using ImageJ and droplet velocity measured for a
range of applied pressures and lipid concentrations.
Results
We present a droplet microfluidic platform that enables the miniatur-
isation and automation of DIB techniques allowing both short- and
long-term fluorescent assays to be performed. Key characteristics of the
proposed system are the use of nL-sized psW/O droplets which mini-
mise assay costs and a bespoke microfluidic network which ensures
DIB formation in a computer controlled format, allowing fast and
reconfigurable start/stop of experimentation.
Device Geometry. We designed and validated a microfluidic
structure capable of the following integrated serial functions:
droplet production, droplet alternation, in-line change of droplet
velocity, DIB formation and storage of DIB arrays (Figure 1).
The microfluidic design comprises a double T-junction (for drop-
let formation), a Y-junction (for droplet alternation, Figure 1B), a
bypass channel (to adjust the velocity of the droplets, Figure 1C) and
a series of microfluidic shift registers22 (for droplet trapping, DIB
formation and storage, Figures 1D, E & F). Briefly, a droplet shift
register is a microfluidic structure that allows droplets to flow within
a central channel formed by pillars while the oil phase also flows
outside the pillars. This allows a balance between hydrodynamic
and interfacial tension forces to be established across the length of
the register (Figures S1 in ESI). Such force balance determines how
many droplets can be stored within a register. When the register is
filled with droplets, an additional droplet forces the first one in line at
the downstream side to exit the register through an aperture, creating
a serial shift of the drops stored within the pillars (Movie S1C in ESI).
Hence, DIB formation is achieved when any two psW/O droplets
come into contact within a register and the lipid molecules at each
droplet interface self-assemble into a lipid bilayer (Figure 1G). The
register structures can be tuned to form the desired droplet train
length (i.e. DIB array) and enable from one to an array of DIBs to
be formed in series (Figure S2 in ESI).
Droplet trapping and storage was facilitated by the shape of the
pillars within a register (Figures 1E & F), locking each droplet into
position due to surface tension forces once the oil flow was stopped.
Outlet 2 (Figure 1A) allowed the extraction of residual air when
initially filling the device. This outlet was subsequently blocked
and not used during normal device operation, thus forcing fluids
through the passive network of registers. Of particular benefit for
reliable DIB formation was the addition of a by-pass channel
(Figure 1C). This feature facilitates control over droplet velocity,
allowing a reduction in droplet speed by diverting only the continu-
ous phase towards the outlet. Reduction in velocity ultimately
increased trapping efficiency and prevented droplet coalescence
(i.e. see paragraphs on DIB stability).
Examples of device operation are shown in Movies S1A-C. It is
worth noting that in all experiments droplet shrinkage occurred
over time, due to fluid absorption through the PDMS walls
(both hexadecane and aqueous phase). To minimise this effect all
devices were immersed in water for at least one hour prior to experi-
mentation, obtaining a 16% droplet area decrease after 40 minutes
(Figure S3 in ESI).
DIB Stability. An essential requirement for robust DIB formation is
that two phospholipid-enveloped droplets must come into contact
without merging. For this to happen, the concentration of phos-
pholipids adsorbed at the oil-water interface must be sufficiently high
to prevent coalescence of two aqueous droplets upon contact. Both
thermodynamic and fluid-dynamic effects will influence the lipid
behaviour at a droplet interface within a microfluidic flow.
To investigate this condition, we characterised droplet coalescence
within shift register structures as a function of lipid concentration
and droplet velocity (where droplet velocity is defined here as the
constant velocity of a droplet flowing in a rectangular microchannel
before entering a shift register structure). For each lipid concentra-
tion tested (all above their respective CMC), the droplet diameter was
kept constant by adjusting the ratio of aqueous to oil phase pressure
at the inlets, thus enabling a range of droplet velocities to be obtained
for similarly sized droplets. The frequency of droplet coalescence
for a particular lipid concentration decreased with decreasing
droplet velocity (Movie S2, S3 & S4 in ESI). Overall, a threshold
velocity was observed separating coalescing droplets and non-coales-
cing droplets against increasing lipid concentration, a trend which
can be considered linear in first approximation (Figure 2). Collisions
above the threshold line exhibited a higher likelihood of droplet
coalescence, whereas below this line emulsions remained stable
and coalescence never occurred. This trend proved valid for different
types of phospholipids (asolectin, DPhPC and DOPC), although
threshold values varied (data not shown). Additionally, to investigate
whether coalescence was dependent on the phase in which lipids
were added, for each concentration, tests were carried out where
lipids were suspended in the aqueous phase as liposomes, dissolved
within the oil phase or added to both phases at the same time. No
coalescence trend was identified for these different cases, indicating
Figure 2 | Relationship between droplet velocity and lipid concentration.
The aqueous phasewas a physiological buffer, the oil phasewas hexadecane
and asolectin was dissolved in one phase only or in both. At higher lipid
concentrations and lower droplet velocities, droplets became less
susceptible to coalescence upon contact within the registers. The dashed
line shows an approximately linear dependence between lipid
concentrations and droplet velocity.
www.nature.com/scientificreports
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that coalescence was not dependent on the phase in which the lipids
were present.
It is also worth noting that increasing lipid concentration resulted
in a decrease of interfacial tension (Figure S4 in ESI). At lower inter-
facial tensions, droplets were more deformable thus lowering the
trapping efficiency and effecting DIB formation.
Fluorescent assays. After DIB formation, transport through a lipid
bilayer of either fluorescent dyemolecules due to passive diffusion or
Ca21 ions across ion channels was tested, demonstrating proof-of-
concept results and the suitability of the proposed microfluidic
system for automated and scalable DIB-based permeation assays
based on fluorescence. Furthermore, both dye leakage and ion
channel experiments (Figures 3 & 4) demonstrated that DIB
formation occurred, if not instantaneously, within a few minutes
from droplet contact for all lipid concentrations tested. Each
experiment was repeated a minimum of 3 times.
First, a membrane permeability assay23 was employed to charac-
terise the leakage of fluorescent molecules through a microfluidic
DIB. This assay was performed by comparing the passive transfer
of fluorescein and its derivative, calcein (bis[N,N0-di(carboxy-
methyl)-aminoethyl] fluorescein). Molecules with a lower charge
are more permeable through a lipid layer than those with a higher
charge24,25. At neutral pH, the fluorescein and calcein moiety is
mainly found as monoanios and dianions, with fluorescein yielding
mainly monoanions and calcein yielding mainly dianions. Since
monoanions are the only form that permeates the lipid bilayer, drop-
lets containing fluorescein are expected to permeate a lipid bilayer
faster than those containing calcein due to the lower charges of these
species in solution. To confirm this, we formed psW/O droplets in an
ABAB configuration, with one droplet encapsulating a fluorescent
buffer (with either fluorescein or calcein) and its neighbour contain-
ing a non-fluorescent buffer (Figure 3). The permeation of fluor-
escent molecules was monitored immediately after droplet
arraying and DIB formation for a period of one hour. As expected25,
after approximately 20 minutes, fluorescein was detected leaking
through the lipid interface, as the fluorescence of the acceptor droplet
increased. Contrarily, no significant fluorescence increase was
detected when using calcein.
Finally, the ability of a microfluidic DIB to harbour ion channels
was tested. The pore forming protein a-haemolysin, a lipid bilayer
spanning toxin which forms a heptameric beta-barrel structure26,
was utilised to fluorescently detect diffusive Ca21 flux (Figure 4)
using Fluo-8, a bilayer-impermeable dye that increases in fluor-
escence when bound to calcium. Arrays of droplets in ABAB
configuration were produced, with one droplet encapsulating
a-haemolysin monomers in a Ca21 buffer and its neighbour contain-
ing a Fluo-8 in an isosmotic K1 buffer. The permeation of fluorescent
molecules was monitored immediately after droplet arraying and
DIB formation for a period of one hour. As a-haemolysinmonomers
spontaneously inserted into the bilayer, an ion channel pore was
formed allowing the permeation of ions, but not Fluo-8 molecules.
Consequently, a stark increase in fluorescence could be observed
over time as a result of the facilitated diffusion of Ca21 through the
a-haemolysin pores and subsequent binding to Fluo-8 (Movie S5 in
ESI). From Figure 4, it can be observed that the middle droplet
became fluorescent at a faster rate than the side droplets, due to
Figure 3 | Passive molecular transport across microfluidic DIBs (A & B).
Fluorescent (donor) and non-fluorescent (acceptor) droplets were trapped
within registers and images where acquired every 5minutes for 1 hour. The
left hand column shows fluorescence microscopy images taken using a
FITC filter. The corresponding bright field can be seen in the right hand
column. 10 mg/ml asolectin was used and fluorescent droplets contained
either 100 mM fluorescein (A) or 100 mM calcein (B). Fluorescein was
clearly observed to leak through the lipid layer, increasing the fluorescent
contents of adjacent droplets whilst calcein did not permeate through to
the neighbouring droplet over the same time period.
Figure 4 | a-haemolysin pore formation in microfluidic DIBs. Acceptor
droplets (1, 3 and 5) containing 250 mM Fluo-8, 10 mM HEPES, 333 mM
EDTA, 2M KCl and donor droplets (2 and 4) containing, 2 mg/ml
a-Haemolysin, 10 mM HEPES, 20 mM EDTA, 1M CaCl2 pH 7.4 were
trapped in ABABA configuration. Incorporation of the a-haemolysin pore
into the DIB produced a diffusive calcium flux into the neighbouring
droplets. The left hand column shows fluorescence microscopy images
taken using a FITC filter. The corresponding bright field can be seen in the
right hand column. 5 mg/ml DPhPC was used. Movie S5 in ESI shows the
increase in fluorescence intensity over time.
www.nature.com/scientificreports
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the fact that two DIBs were interfaced to the Fluo-8 containing
droplet. After 15 min all three acceptor droplets were seen to reach
a similar level of fluorescence as Fluo-8 molecules were saturated.
As a control, the same experiment was carried out with droplets
lacking in a-haemolysin monomers. The process was monitored
over the same time period and no detectable increase in fluorescence
was observed (Figure S5 in ESI). Ion flux through DIBs varied
amongst experiments due to the stochastic nature of monomer
insertion and pore formation in a lipid bilayer.
Discussion
The analysis that follows presents our findings concerning the per-
formance of the system, the limitations of the current microfluidic
design and a discussion for future improvements.
Device geometry. Two important features of droplet microfluidics
are the throughput of experiments and the potential for automation
that can be achieved with the technology20. The exploitation of these
properties is therefore very attractive for scaling up biomembrane
studies and developing synthetic biology-based procedures related to
artificial lipid bilayers and ion channels.
Let’s consider scalability and throughput for screening purposes.
Regarding the permeation of a compound through a DIB, increasing
the throughput of result by scaling up the register network can be
particularly useful for either extracting statistical information from
a single device using one compound or when testing a variety of
compounds at the same time. However, considering the trade-off
identified for lipid concentration and droplet velocity to avoid drop-
let coalescence (Figure 2) and the serial link between registers, it
follows that the throughput of DIB experiments that can be carried
out in parallel is proportional to the time that takes to fill the register
network. Therefore, the throughput of significant experiments that
can be carried out in parallel with the proposed system is directly
related to the timescale of the process (TP) occurring across the lipid
bilayer. This is important because if the permeation of a compound
through a lipid bilayer (or ion channels) occurs in a faster timescale
than that required for a droplet to shift along a register, a droplet
content would permeate across a DIB during the filling procedure of
the register network.
To illustrate this, let’s consider a system of N shift registers where
only two droplets can be stored in each register (Figure S6A in ESI).
In this case, a total time of TTOT5(2*N*TD)1(N21)*TT is required
to fill the N registers, where TD is the interval of time at which a
droplet reaches any register in a steady state condition and TT is the
droplet travelling time between equidistant registers (condition that
can be generalised to TTOT5(M*N*TD1(N21)*TT) for a register
that stores M droplets at the same time). Importantly, by the time
all N registers are full, due to the serial connection between the
registers, a droplet (e.g. D1 in Figure S6A in ESI) would have been
in touch with any adjacent droplet for a time TC5N*TD during the
filling procedure (resulting in TC5N*(M21)*TD for a register that
stores M droplets at the same time). Therefore, at the time of mon-
itoring N experiments in parallel (i.e. all the register are full and no
more droplets are produced), the permeation process taking place
across the final DIB had already been occurring in previous registers
during the filling procedure. This identifies a trade-off between TTOT
and TC and the time constant, TP, associated with the molecular
transport dynamics across a DIB.
As an example, the device used in Movies S1A-C consisted of 15
registers each containing 5 droplets (4 DIBs per register) and there-
fore, considering a lipid concentration of 5 mg/ml, a time of 5–20
minutes is required to fill all the registers depending on the type of
lipids used (e.g. DPhPC enabled much higher velocities than asolec-
tin, as also previously reported15). This effect is shown when using
calcein (TP?TTOT, Figure S6B in ESI) and fluorescein (TP=TTOT,
Figure S6C in ESI), molecules that passively cross a DIB at different
rates. In the final state after filling the first nine registers, while
all DIB arrays can be simultaneously monitored for calcein-filled
droplets (Figure S6B in ESI), only the first two registers can be
simultaneously monitored for fluorescein-filled droplets (as fluores-
cein had considerably leaked through DIBs during the filling
procedure, Figure S6C in ESI).
In conclusion, to address scalability of operation and throughput
of results, a dual approach should be undertaken where only 1 or a
small number of registers should be used in the network via auto-
matic start/stop of droplet production in the case of TP,TTOT,
whereas due to fast dynamics of mass transport many experiments
must be repeated periodically. Although the case of TP, TTOT does
not occur frequently, some drugs have been reported in this range27.
Contrarily, a proportionally larger number of registers can be
monitored simultaneously for conditions where TP.TTOT, whereas
due to slow dynamics of mass transport many experiments can be
monitored in parallel.
Finally, attention should also be placed on the type of carrier fluid
and device material used. In our work, except for minor advantages
in reducing PDMS swelling with respect to other solvents, hexade-
cane was primarily used as it has been consistently reported that
increasing the n-alkane chain length of the oil increases the chances
of obtaining oil-free conditions within a lipid bilayer28, thus forming
DIBs with a more similar environment to that found in live cell
membranes. Further advantages can also be gained by fabricating
the microfluidic devices with transparent materials that do not
absorb solvents and are not gas and water permeable, such as
poly-methyl-methacrylate, polystyrene or glass, resolving the issues
associated with temporal droplet volume variation when performing
long-term assays.
DIB stability. The observed decrease in droplet coalescence for
increasing lipid concentrations is consistent with previous reports18
for DPhPC bilayers formed between a resting aqueous droplet in
hexadecane and an agarose substrate in static conditions. In addi-
tion, a trend where higher lipid concentrations induced longer-
lasting bilayers has also been reported, with the self-assembly
process (i.e. from multilamellar to bilayer) of lipids at the droplet
interface taking longer to occur for higher lipid concentration18. In
our system instead, if coalescence did not occur within seconds after
contact between droplets, DIB coalescence was never observed.
In static or ‘slow’ dynamic conditions, droplets coalescence can
be avoided by sufficiently increasing the phospholipid concentra-
tion thus ensuring phospholipid coverage at a droplet interface1.
Differently, for ‘fast’ dynamic conditions, the lipid coverage at a
droplet interface depends also on the hydrodynamic forces and the
aqueous solutions used29,30. On one side, the faster a droplet moves,
the greater the lipid adsorption rate at its interface31. On the other,
lipids at the front of a travelling droplet tend to be displaced to the
back of the droplet interface, creating a gradient of interfacial tension
and leading to lipid depletion at the front of the droplet32. This
localised decrease in lipid concentration can induce coalescence
upon collision of phospholipid stabilised W/O droplets. The
dynamics of emulsion stability has been previously investigated in
rectangular microchannels33,34. Both studies have described the rela-
tionship between the rate of droplet coalescence and surfactant con-
centration depending on the size and dispersion of a group of
colliding droplets within a microfluidic chamber. Additionally, pre-
vious reports29,35 have also described coalescence effects in micro-
droplets when fast fluid dynamics induce a local depletion of the
surfactant at the interface between two contacting droplets. Finally,
droplet stabilization in ‘very fast’ flow rates (i.e. twice the magnitude
than in our system) has also been investigated31. For the microchan-
nel geometry used and a continuous train of adjacent droplets,
a trend was identified where higher droplet velocities reduced
the coalescence rate of phospholipid stabilised droplets. Overall,
www.nature.com/scientificreports
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regardless of the microfluidic geometry, it can be concluded that to
avoid droplet coalescence it is necessary to ensure that the lipid
adsorption dynamics at a W/O interface are faster than the lipid
depletion dynamics caused by interfacial shear before droplet
collision.
Specific to this work, Figure 5 shows schematically the two pos-
sible scenarios that can occur during a droplet arraying process
within a shift register. In both cases, we consider the first droplet
as static (already trapped in a register), while the second is approach-
ing and eventually contacts the first to form a DIB. Both droplets are
exposed to interfacial shear stress caused by the drainage of the
interstitial oil (through the gap between pillars in a shift register
structure - arrows in Figure 5), which occurs as the moving droplet
approaches the resting one. If droplet velocity is used as a measure of
the shear stress at a droplet interface moving in a rectangular chan-
nel, a higher velocity corresponds to greater shear30, causing a more
pronounced change in the phospholipid distribution at the droplet
interface. Consistent with what was discussed above, a high shear
stress induces a rapid depletion of the phospholipid film, rendering
emulsion interfaces prone to coalescence (Figure 5A). Successful
formation of DIB occurs when lipid adsorption dynamics are dom-
inant over interfacial phospholipid depletion, thus preventing
coalescence. When analysing the magnitudes of the velocities of
psW/O droplet trains in rectangular microchannels in the literat-
ure15,16, similar velocity values to those identified in Figure 2 are
obtained, suggesting that the considerations outlined above are gen-
erally applicable to phospholipid stabilised emulsions at the micro-
scale. In conclusion, the correlation between droplet velocity, lipid
concentration and coalescence can be identified for a specific lipid
mixture and this information then used for instructing the design of
the channel network.
Fluorescent assays. The importance of carrying out permea-
tion assays in vitro and both the qualitative and quantitative
estimation of ion-channel mediated molecular transport is well
documented25,36,37. A system that can allow such assays to be per-
formed in an automated and customisablemanner can therefore find
applications in the pharmacokinetic screening of compounds during
the drug development process. Here, proof-of-concept data is shown
estimating the permeability of fluorescein throughmicrofluidic DIBs
and ion transport across a-haemolysin bearing DIBs. To evaluate the
permeation of substances from a donor droplet to an acceptor
droplet, we used the apparent permeability index Papp
36, which was







where CD0 is the initial concentration of the compound in the donor
droplet, CR(t) is the concentration of the compound in the acceptor
droplet over time, A(t) is the estimated total surface area of the DIB
(i.e. taking into account that some droplets had two DIBs) and VR(t)
is the estimated volume of the acceptor droplet over time. The
droplet volumes and DIB surface areas at each time point were
estimated from the respective microscopy images (approximating
droplets to ellipsoids and DIB areas to ellipses). The calculation
takes into account variability in droplet size and bilayer area for all
measurements, therefore temporal changes do not affect the estimate
of the permeability coefficient. As the fluorescence intensity is
proportional to molecular concentration, the intensity values were
used as a proxy for compound concentration. The estimated Papp
value for fluorescein at pH 7.4 was 2.0131026 6 1.4631026 cm/s
(calculated from 5 different experiments) which falls within the
range reported in the literature between 1.631026 cm/s and
21.231026 cm/s25,37,38 according to the pH used.
The ability of fluorescein, but not calcein, to traverse the DIB
confirmed the formation of a selectively permeable lipid interface.
However, it is important to note that dye leakage experiments do not
prove the existence of a lipid bilayer (whilst the flow of ions through
a-haemolysin pores does). Previous reports have in fact shown that
the interactions between lipid molecules and dyes are dependent on
the number of lipid layers (or lipid multilayer), with leakage time
being directly proportional to the number of lipid layers39. The esti-
mated Papp value for Ca
21 ion across a-haemolysin pores was
7.0831026 6 1.7631026 cm/s (calculated from 3 different experi-
ments) for the concentration of monomers used. This approach can
provide an insight into the transport dynamics through ion channels
when, for instance, determining the effects on ion flux through pro-
teins caused by blocking agents17. To quantify the concentration of
calcium ions within an acceptor droplet at different time points, a
calibration curve was also produced (Figure S7 in ESI).
The ability to qualitatively (and potentially quantitatively) identify
DIB permeation values demonstrates the suitability of our system for
investigating processes occurring across an artificial lipid bilayer in a
miniaturised and scalable format.
Conclusions
We have developed and validated a microfluidic network based on
pressure driven flow, capable of stable and robust psW/O droplet
generation, alternation and trapping within register elements for the
Figure 5 | Schematic representation of coalescence (A) and
non-coalescence (B) mechanisms of psW/O droplets within a shift
register due to a difference in droplet velocity (solid arrows, velocities
above threshold; dashed arrows, velocities below threshold with respect
to graph in Figure 2). During normal device operation, when a droplet
reaches an empty shift register it remains trapped within the pillar
structure if the correct balance between the hydrodynamic pressure
difference between the inlet and outlet points of the register and the
Laplace pressure of the droplet interface is achieved. Because the oil is
flowing within the register and exiting through the gaps between the
pillars, the interface of a trapped droplet can be depleted of phospholipids
proportionally to the magnitude of the shear forces parallel to the oil flow
directions. When a second droplet, presenting a phospholipid-depleted
front interface, enters the register, the oil layer between the two drops is
drained through the pillars and contact between the two psW/O droplets
will occur. Depending on the phospholipid adsorption dynamics,
(i.e. phospholipid concentration andmagnitude of hydrodynamic forces),
the two droplets will coalesce depending on the degree of phospholipid
coverage at both droplet interfaces.
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formation of a series of DIB arrays of desired length and their storage.
First, we have identified an important relationship between the drop-
let velocity and lipid concentration which identifies the conditions to
prevent droplet coalescence without hindering themicrofluidic func-
tionalities of our system. Then, we have discussed how the scalability
and throughput of results depends on the serial connectivity of the
register network and the dynamics of mass transport occurring
across a DIB. Finally, we have demonstrated the successful formation
of lipid bilayers, providing proof-of-concept results of passive
molecular permeation and ion-channel mediated permeation of
molecules and ions through DIBs using fluorescent assays. The pro-
posed system can lead to new platforms for higher-throughput and
miniaturised version of parallel artificial membrane permeability
assays (PAMPA) and being applied to large-scale studies of processes
occurring across artificial lipid bilayers, such asmolecular transport8,
fusogenic properties of peptides40 and virus transport and fusion41.
Furthermore, the architecture has also potential to be utilised
for drug discovery assays using non self-inserting eukaryotic trans-
membrane proteins. However, these are typically non water-soluble
proteins and require amicellar or liposome environment tomaintain
functionality before reconstitution into a DIB. This is a challenging
task and further improvement, both procedural and technological,
are required, for instance, by optimising protocols for either cell free
expression of transmembrane proteins42 or proteoliposome deliv-
ery14 in droplet-based systems. The integration of microelectrodes
is also possible which will allow for large scale electrophysiology
readouts43,44, allowing more sensitive assays to be performed than
those obtained with fluorescent dye reporters. However, this
approach increases the complexity associated with systemmicrofab-
rication and costs. Finally, the integration of on-demand droplet
production45 with multiple inlets may enable the automated and
combinatorial arraying of DIB networks to be obtained for testing
multiple compounds within one device.
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